When is it appropriate to stop? Developing an M&E strategy to guide triple drug stopping decisions for lymphatic filariasis
Researchers
- Associate Professor Colleen Lau (Primary Investigator)
Grant status
CompletedGrant start date
25/05/2018Grant funding
- 2018: $427,821 from The Task Force for Global Health
